Pfizer 2Q Profit Surges, Company Sees Drug Rebates Ending

By THE ASSOCIATED PRESS
NYT
Pfizer's top executives are predicting the Trump administration will try to eliminate big rebates off prescription drug prices that manufacturers pay to middlemen, a move that could sharply reduce patients' out-of-pocket costs.
Published date: July 31, 2018 at 02:08PM
AP
New York Times article